Aberrant markers expression in leukemia patients: a report from Western Iran

Journal Title: Scholars Journal of Applied Medical Sciences - Year 2016, Vol 4, Issue 3

Abstract

Leukemia’s comprise approximately 8% of the entire human cancers, and around 50% of these cases are classified as acute leukemia. The aim of this study was to evaluate the aberrant markers in leukemia’s in the West of Iran. In an analytical-descriptive study, we analyzed the report of flowcytometry of peripheral blood samples from leukemia patients in Dr. Mohammad Kermanshahi Hospital, Kermanshah city, Iran. Age and sex were identified for every patient. Aberrant Markers of flow cytometry were checked for a number of patients. Positive staining of the markers was shown based on three cuts-off that >15%, >20% or >30%. Out of 132 leukemia samples, 67 cases (50.8%) had CLL (all B-CLL), 38 cases (28.8%) had ALL (11 T-ALL and 27 B-ALL) and 27 cases (20.4%) had AML-non M3. The mean age at diagnosis for CLL patients was 65.3 years, AML 39.2 years and ALL 13.6 years. CD2, CD3 and CD7 were checked in some of B-CLL and AML-non M3 patients and CD3 in B-ALL patients as aberrant markers and showed positivity, however, further studies are needed for evaluation of prognosis, therapy, response and survival in patients with these aberrant markers. Keywords: Leukemia’s, aberrant markers, Cut-off

Authors and Affiliations

Mazaher Ramezani, Somaye Hosseini, Asad Vaisi- Raygani, Mansour Rezaei, Masoud Sadeghi

Keywords

Related Articles

Nutritional status of Adolescents in Benghazi

Abstract: The recent increase in both adolescent over-weight and obesity in the developing world has underlined the important consequences these trends may impact on public health. Therefore, it is necessary to monitor p...

A Prospective Study of Severe Pre-Eclampsia in Pregnancy

To determine the age, parity, gestational age, mood of delivery and perinatal outcome in pregnant women with severe pre-eclampsia. The study covers 1year period, during which 200 patients with severe pre-eclampsia were s...

Microalbuminuria in Normotensive Type 2 Diabetic Patients

Abstract: Microalbuminuria denotes an abnormally increased excretion rate of albumin in the urine in the range of 30–299 mg/g creatinine. Microalbuminuriais considered as a marker of diabetic nephropathy. The American Di...

Sexual Dysfunction in Women Being Treated with SSRIs

Abstract: Selective Serotonin Reuptake Inhibitors (SSRIs) are the most commonly prescribed drugs for depression and anxiety disorders. We aimed to evaluate treatment-emergent sexual dysfunction (SD) in 100 women who were...

Microbiological Infectivity in Medical Laboratory Benghazi, Libya

Abstract: We surveyed environmental surfaces in our clinical microbiology laboratory one at Reference laboratory, Benghazi and other at Pediatric Hospital Laboratory to determine bacterial contamination during a routine...

Download PDF file
  • EP ID EP371349
  • DOI -
  • Views 45
  • Downloads 0

How To Cite

Mazaher Ramezani, Somaye Hosseini, Asad Vaisi- Raygani, Mansour Rezaei, Masoud Sadeghi (2016). Aberrant markers expression in leukemia patients: a report from Western Iran. Scholars Journal of Applied Medical Sciences, 4(3), 1035-1038. https://europub.co.uk/articles/-A-371349